sanofi
(3)
Kimberly Hairston-Hicks Builds Brands From the Human Truth Out
She wanted to be the next Oprah. Instead, a chance conversation led her to brand management, the beauty industry, and a career built on one persistent question: who is the market still failing to see?
Bozidar Jovicevic
Bozidar Jovicevic is the CEO and co-founder of Evermed, a New York startup that lets medical societies and healthcare organizations launch a Netflix-style, on-demand video library in about 90 days. A medical doctor and FIDE chess master who spent 17 years running global digital initiatives at Novartis and Sanofi, he now builds technology that turns conference recordings and expert lectures into searchable, monetizable continuing-education libraries for physicians. He also hosts the Pharma Launch Secrets and Digital Innovators Circle podcasts.
Michael Shih
Michael Shih is the Chief Executive Officer of NeoPhore Ltd, a London-based small molecule neoantigen immuno-oncology company developing first-in-class drugs that target the DNA mismatch repair (MMR) pathway to make cancers more visible to the immune system. An attorney by training with degrees in biology, he spent nearly two decades structuring biotech deals before sitting in the chief executive's chair, with senior business development and corporate development roles at Kite Pharma, Biogen, Sanofi, Epizyme, Forest Laboratories, Kastle Therapeutics and Eisai. He took the helm at NeoPhore in December 2024, right after the company closed an oversubscribed Series B round backed by Bristol Myers Squibb.